Monocyte chemotactic protein-1 (MCP-1) regulates activated remodeling

来源 :第七届国际骨质疏松及骨矿盐疾病学术会议 | 被引量 : 0次 | 上传用户:countrygary
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Monocyte chemotactic protein-1 (MCP-1) belongs to the CC chemokine superfamily (as CCL2).It plays a critical role in recruitment and activation of leukocytes during acute inflammation, and has the highest level of gene induction in bone following anabolic PTH treatment1.
其他文献
Background: Women with breast cancer (BC) are at high risk for fracture due to the deleterious impact of BC therapies on bone.In China, BC survival is improving as screening and treatment programs exp
会议
研究目的 对DANCE研究中有髋部骨折史的患者进行回顾性分析.评估有髋部骨折史患者接受特立帕肽治疗后的非椎体骨折发生率.方法 DANCE是一项前瞻性的观察研究.该研究中,给予社区骨质疏松患者最长2年的特立帕肽治疗,治疗结束后继续随访最长2年.4085例患者至少接受1次特立帕肽(20 μg/天)治疗,其中329例患者接受治疗前有髋部骨折史.本研究比较了有髋部骨折史患者和无髋部骨折史患者的基础人口学数
会议
研究目的 原发性厚皮性骨膜增生症(Primary hypertrophic osteoarthropathy;PHO)是一种罕见的常染色体隐性遗传疾病,主要临床特征包括杵状指、厚皮及骨膜增生.我们之前的研究在国际上首先报告除HPGD突变外,PHO的另一个致病基因为SLCO2A1基因.本研究目的在于研究一组PHO患者,鉴定致病基因,并分析临床表型.
会议
Background: The purpose of this article is to study the change of bone mineral density (BMD) in periarticular subchondral regions of the knee joint in the patients with osteoarthritis (OA) of the knee
会议
Background: The aim of the study was to evaluate the Bone Mineral Density (BMD), Trabecular Bone Score (TBS) in men of various ages suffering from a late-onset hypogonadism (LOH).
会议
Background: Natural herbal therapy offers an attractive alternative for the treatment of osteoporosis.The objective of this study is to evaluate the efficacy and safety of natural Chinese herbs, Zuogu
会议
Background: To examine the association of nutritional and dietary factors with risk of hip fractures in elderly Chinese men and women.Methods: 724 (M/F: 177/549) incident cases of hip fractures were e
会议
Background: study the relationship between serum vitamin D level and blood glucose in type 2 diabetic osteoporosis patients.Methods: 84 type 2 diabetes patients were selected from the Second Division
会议
Background: Bisphosphonates (BPs) are therapeutic agents for treatment of bone disorders such as osteoporosis and Paget s disease.Several nitrogen-containing bisphosphonates (N-BPs) and phosphonocarbo
会议
Background: Increased vascular permeability is one of the first stages in both physiological and pathological angiogenesis.Osteoporosis accompanies with reduced angiogenesis and vascularization.Howeve
会议